SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025
SS Innovations International (OTC: SSII) unveiled its groundbreaking SSI Mantra Tele-Sync Mobile Unit (SSI MantraM) at the Second Global Multi-Specialty Robotic Surgery Conference in Gurugram, India. This first-of-its-kind mobile tele-surgical unit integrates the SSi Mantra 3 Surgical Robotic System with high-speed connectivity to enable remote surgical procedures.
The conference attracted over 1,200 medical professionals. The SSI MantraM is designed to provide robotic-assisted surgery to underserved communities through telesurgery capabilities and real-time collaboration between remote and on-site surgical teams. Notably, the SSi Mantra 3 system is the only robotic system globally to receive CDSCO regulatory approval for telesurgery and tele-proctoring.
The system features 3-5 robotic arms, 3D 4K monitoring, and supports over 40 different types of robotic endo-surgical instruments across various specialties. The company anticipates receiving FDA and CE Mark approval in the second half of 2025.
SS Innovations International (OTC: SSII) ha presentato la sua innovativa Unità Mobile Tele-Sync SSI Mantra (SSI MantraM) alla Seconda Conferenza Globale di Chirurgia Robotica Multispecialistica a Gurugram, India. Questa unità telechirurgica mobile, la prima del suo genere, integra il Sistema Robotico Chirurgico SSi Mantra 3 con connettività ad alta velocità per consentire procedure chirurgiche a distanza.
La conferenza ha attirato oltre 1.200 professionisti medici. La SSI MantraM è progettata per fornire chirurgia assistita da robot a comunità svantaggiate attraverso capacità di telechirurgia e collaborazione in tempo reale tra team chirurgici remoti e in loco. È importante notare che il sistema SSi Mantra 3 è l'unico sistema robotico a livello globale ad aver ricevuto l'approvazione normativa CDSCO per la telechirurgia e il tele-proctoring.
Il sistema presenta 3-5 braccia robotiche, monitoraggio 3D 4K e supporta oltre 40 diversi tipi di strumenti endo-chirurgici robotici in varie specialità. L'azienda prevede di ricevere l'approvazione della FDA e il marchio CE nella seconda metà del 2025.
SS Innovations International (OTC: SSII) presentó su innovadora Unidad Móvil Tele-Sync SSI Mantra (SSI MantraM) en la Segunda Conferencia Global de Cirugía Robótica Multispecializada en Gurugram, India. Esta unidad telequirúrgica móvil, la primera de su tipo, integra el Sistema Quirúrgico Robótico SSi Mantra 3 con conectividad de alta velocidad para permitir procedimientos quirúrgicos remotos.
La conferencia atrajo a más de 1,200 profesionales médicos. La SSI MantraM está diseñada para proporcionar cirugía asistida por robot a comunidades desatendidas a través de capacidades de telecirugía y colaboración en tiempo real entre equipos quirúrgicos remotos y locales. Cabe destacar que el sistema SSi Mantra 3 es el único sistema robótico a nivel mundial que ha recibido aprobación regulatoria CDSCO para telecirugía y tele-proctoring.
El sistema cuenta con 3-5 brazos robóticos, monitoreo 3D 4K y soporta más de 40 tipos diferentes de instrumentos endoquirúrgicos robóticos en varias especialidades. La empresa anticipa recibir la aprobación de la FDA y la marca CE en la segunda mitad de 2025.
SS Innovations International (OTC: SSII)는 인도 구르가온에서 열린 제2회 글로벌 다전문 로봇 수술 회의에서 혁신적인 SSI Mantra Tele-Sync 모바일 유닛 (SSI MantraM)을 공개했습니다. 이 최초의 모바일 원격 수술 유닛은 SSi Mantra 3 수술 로봇 시스템과 고속 연결을 통합하여 원격 수술 절차를 가능하게 합니다.
이번 회의에는 1,200명 이상의 의료 전문가가 참석했습니다. SSI MantraM은 원격 수술 능력과 원격 및 현장 수술 팀 간의 실시간 협업을 통해 소외된 지역 사회에 로봇 보조 수술을 제공하도록 설계되었습니다. 특히 SSi Mantra 3 시스템은 원격 수술 및 원격 감독을 위한 CDSCO 규제 승인을 받은 전 세계 유일의 로봇 시스템입니다.
이 시스템은 3-5개의 로봇 팔, 3D 4K 모니터링을 갖추고 있으며 다양한 전문 분야에서 40종 이상의 로봇 내시경 수술 기구를 지원합니다. 회사는 2025년 하반기에 FDA 및 CE 마크 승인을 받을 것으로 예상하고 있습니다.
SS Innovations International (OTC: SSII) a dévoilé sa SSI Mantra Tele-Sync Mobile Unit (SSI MantraM) révolutionnaire lors de la deuxième conférence mondiale de chirurgie robotique multispecialisée à Gurugram, en Inde. Cette unité téléchirurgicale mobile, la première de son genre, intègre le Système Robotique Chirurgical SSi Mantra 3 avec une connectivité haut débit pour permettre des procédures chirurgicales à distance.
La conférence a attiré plus de 1 200 professionnels de la santé. La SSI MantraM est conçue pour fournir une chirurgie assistée par robot aux communautés mal desservies grâce à des capacités de téléchirurgie et une collaboration en temps réel entre les équipes chirurgicales à distance et sur site. Notamment, le système SSi Mantra 3 est le seul système robotique au monde à avoir reçu l'approbation réglementaire CDSCO pour la téléchirurgie et le télé-proctoring.
Le système dispose de 3 à 5 bras robotiques, d'une surveillance 3D 4K et prend en charge plus de 40 types différents d'instruments endo-chirurgicaux robotiques dans diverses spécialités. L'entreprise prévoit de recevoir l'approbation de la FDA et le marquage CE dans la seconde moitié de 2025.
SS Innovations International (OTC: SSII) stellte auf der zweiten globalen Konferenz für robotergestützte Chirurgie in Gurugram, Indien, ihre bahnbrechende SSI Mantra Tele-Sync Mobile Unit (SSI MantraM) vor. Diese erste ihrer Art mobile telechirurgische Einheit integriert das SSi Mantra 3 Chirurgische Robotersystem mit Hochgeschwindigkeitsverbindungen, um chirurgische Eingriffe aus der Ferne zu ermöglichen.
Die Konferenz zog über 1.200 medizinische Fachkräfte an. Die SSI MantraM wurde entwickelt, um robotergestützte Chirurgie in unterversorgte Gemeinschaften durch Telechirurgie-Funktionen und Echtzeit-Zusammenarbeit zwischen entfernten und vor Ort tätigen Chirurgenteams zu bringen. Bemerkenswert ist, dass das SSi Mantra 3-System das einzige robotergestützte System weltweit ist, das CDSCO-regulatorische Genehmigung für Telechirurgie und Teleproctoring erhalten hat.
Das System verfügt über 3-5 Roboterarme, 3D 4K-Überwachung und unterstützt über 40 verschiedene Arten von robotergestützten endochirurgischen Instrumenten in verschiedenen Fachrichtungen. Das Unternehmen erwartet, in der zweiten Hälfte des Jahres 2025 die FDA- und CE-Zulassung zu erhalten.
- First and only robotic system globally to receive regulatory approval for telesurgery
- Expanding market reach to underserved communities through mobile surgical unit
- System validated in 80+ surgical procedures with 40+ instrument types
- FDA and CE Mark approval expected in H2 2025
- Pending FDA and CE Mark approvals create regulatory uncertainty
- Significant competition in global surgical robotics market
FORT LAUDERDALE, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its Mobile Tele-Surgical Unit, aimed at improving remote surgical access and healthcare delivery at the Company’s Second Global Multi-Specialty Robotic Surgery Conference (SMRSC), which was held in Gurugram, Delhi National Capital Region (NCR), India, from March 7 - 9, 2025.
The two-day conference, hosted by SS Innovations, saw enthusiastic participation from over 1200+ medical professionals, who gathered on a single platform to explore the transformative potential of robotic surgery.
In a groundbreaking announcement at the SMRSC, SS Innovations unveiled the SSI Mantra Tele-Sync Mobile Unit – “SSI MantraM”, a first-of-its-kind innovation designed to transform the landscape of robotic surgery and telemedicine in India. This innovative mobile tele-surgical unit reflects SS Innovations’ unwavering commitment to advancing medical technology, redefining healthcare infrastructure, and expanding access to cutting-edge surgical care. With the introduction of the SSI MantraM, SS Innovations continues to expand the boundaries of med-tech, revolutionizing surgical infrastructure and cementing India’s position as a global leader in robotic surgery and health-tech innovation.
Speaking on the launch of SSI MantraM, Dr. Sudhir Srivastava, Founder & Chairman of SS Innovations said, “SSI MantraM is more than a mobile tele-surgical unit, it is an innovative step in the democratization and decentralization of the provision of world-class healthcare. With high-speed telecommunication and satellite connectivity, the SSI MantraM is designed to break geographical barriers, by delivering life-saving robotic-assisted surgery to underserved communities. Beyond tele-surgical procedures, SSI MantraM serves as a platform for surgical education, tele-mentoring, and real-time patient data analytics. With continuous research and innovation, SSI believes that the Company is taking a major step toward ensuring that advanced robotic surgery reaches those who need it most.”
Dr. Michio Kaku, theoretical physicist and futurist, speaking on the future of medical technology added, “Congratulations to SSI for making history by igniting the next revolution in robotic surgery. Today marks the beginning of an exciting new era, with SSI at the forefront of a transformation that will redefine the medical field. When historians look back, they will recognize that this moment set into motion a movement that will reverberate across the world, redefining the way surgery is performed. But this is only the beginning. We are witnessing the dawn of the next phase that goes beyond where we stand today.
While this phase will shape the future for years to come, I can already see the emergence of something even greater: the integration of quantum mechanics into surgery. This will not just be robotic surgery; it will be quantum mechanical robotic surgery, an evolution that will once again revolutionize medicine. Years from now, history will mark SSI as the epicenter of this transformation, the place where visionaries, driven by energy and foresight, propelled this revolution forward. I eagerly await the next great leap, where quantum mechanics and robotic surgery merge, opening yet another frontier in medical innovation.”
Equipped with state-of-the-art telesurgery capabilities, SSI MantraM breaks barriers in surgical care by delivering world-class robotic-assisted procedures to remote and underserved regions. The Tele-Sync Mobile Unit seamlessly integrates the Company’s SSi Mantra 3 Surgical Robotic System, high-speed connectivity, and advanced surgical robotics to enable real-time collaboration between remote and on-site surgical teams. This innovation empowers expert surgeons to perform and guide procedures with minimal latency, making advanced surgical care more accessible than ever.
The SSi Mantra 3 Surgical Robotic System is the only robotic system in the world to have received regulatory approval for telesurgery and tele-proctoring. Approved by the Central Drugs Standard Control Organization (CDSCO), this validation opens the door to remote surgeries and medical education, enabling healthcare professionals to collaborate across great distances. It highlights the transformative potential of technology in enhancing the accessibility and precision of healthcare, revolutionizing how surgeries are performed on a global scale. By offering the potential to bring world-class medical expertise to even the most remote corners of the globe, it sets a precedent for the future of remote healthcare, reshaping patient care.
About SS Innovations:
SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SS Innovations’ business operations are headquartered in India and the Company plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit our website at ssinnovations.com or LinkedIn for updates.
About the SSi Mantra:
The SSi Mantra Surgical Robotic System, by SS Innovations, is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including cardiac surgery. The learning curve for surgeons is shorter due to the SSi Mantra’s ergonomic design and user-friendly features.
The SSi Mantra has been clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Forward-Looking Statements:
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations
For media inquiries, please contact:
+1-212-739-0300
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a85d0f17-c073-4a6d-8a36-a34c284f3673
https://www.globenewswire.com/NewsRoom/AttachmentNg/7f48db39-e385-4955-ad61-4f6cdc1edff8
FAQ
What is the SSI MantraM mobile tele-surgical unit unveiled by SSII?
When does SSII expect to receive FDA and CE Mark approval for the SSi Mantra system?
How many types of surgical procedures can the SSII Mantra system perform?
What regulatory approvals has SSII's Mantra 3 Surgical Robotic System received?
What are the key features of SSII's Mantra Surgical Robotic System?
